These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Felbamate Study Group in Lennox-Gastaut Syndrome N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179 [TBL] [Abstract][Full Text] [Related]
3. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622 [TBL] [Abstract][Full Text] [Related]
7. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Palmer KJ; McTavish D Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493 [TBL] [Abstract][Full Text] [Related]
8. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group. Avanzini G; Canger R; Dalla Bernardina B; Vigevano F Epilepsy Res; 1996 Nov; 25(3):249-55. PubMed ID: 8956923 [TBL] [Abstract][Full Text] [Related]
10. Felbamate: clinical and molecular aspects of a unique antiepileptic drug. Brown WM; Aiken SP Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190 [TBL] [Abstract][Full Text] [Related]
12. [Preliminary assessment of felbamate effect on the cerebral bioelectrical activity in children with refractory epilepsy]. Pakszys M; Rusek G; Kuszczak B; Szamotulska K; Mazur J Neurol Neurochir Pol; 2000; 34 Suppl 1():203-14. PubMed ID: 10768160 [TBL] [Abstract][Full Text] [Related]
13. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692 [TBL] [Abstract][Full Text] [Related]
15. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients. Luer MS Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896 [No Abstract] [Full Text] [Related]
16. Felbamate: consensus of current clinical experience. Pellock JM; Faught E; Leppik IE; Shinnar S; Zupanc ML Epilepsy Res; 2006 Oct; 71(2-3):89-101. PubMed ID: 16889941 [TBL] [Abstract][Full Text] [Related]
17. Felbamate in the treatment of Lennox-Gastaut syndrome. Jensen PK Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473 [TBL] [Abstract][Full Text] [Related]
19. The use of felbamate to treat infantile spasms. Hurst DL; Rolan TD J Child Neurol; 1995 Mar; 10(2):134-6. PubMed ID: 7782604 [TBL] [Abstract][Full Text] [Related]
20. [Positive effect of falbamate therapy in a boy with refractory epilepsy]. Szczepanik E; Pakszys M; Rusek G Neurol Neurochir Pol; 2000; 34 Suppl 1():195-201. PubMed ID: 10768159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]